Efficacy of cetuximab in the treatment of squamous cell carcinoma

Efficacy of Cetuximab for Unresectable or Advanced Cutaneous Squamous Cell Carcinoma — A Report of Eight Cases

(2011) D. Giacchero et al.   CLINICAL ONCOLOGY

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

(2011) Eve Maubec et al.   JOURNAL OF CLINICAL ONCOLOGY

Carcinome épidermoïde cutané (carcinome spinocellulaire) Recommandations de pratique clinique pour la prise en charge diagnostique et thérapeutique

(2009) L. Martin et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial

(2009) Merrill S. Kies et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER